Skip to main content
Apeloa Pharmaceutical Co.,Ltd. logo

Apeloa Pharmaceutical Co.,Ltd. — Investor Relations & Filings

Ticker · 000739 ISIN · CNE000000Q45 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,843 across all filing types
Latest filing 2018-08-07 Interim / Quarterly Rep…
Country CN China
Listing Shenzhen Stock Exchange 000739

About Apeloa Pharmaceutical Co.,Ltd.

https://www.apeloa.com

Apeloa Pharmaceutical Co., Ltd. focuses on the research, development, manufacturing, and distribution of active pharmaceutical ingredients (APIs), intermediates, and finished dosage forms. The company operates three core business pillars: API production, Contract Development and Manufacturing Organization (CDMO) services, and finished drug products. Its therapeutic focus includes cardiovascular, anti-infective, anti-viral, and oncology treatments. Apeloa utilizes an integrated supply chain to deliver chemical and biological solutions to a global client base. The organization maintains compliance with international quality standards, including certifications from the FDA, EMA, and PMDA. Its CDMO services encompass the full product lifecycle, from process chemistry and analytical development to large-scale commercial manufacturing, supported by specialized technology platforms such as continuous flow chemistry and enzymatic synthesis.

Recent filings

Filing Released Lang Actions
2018年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "普洛药业股份有限公司 2018 年半年度报告全文" which translates to "Apeloa Pharmaceutical Co., Ltd 2018 Semi-Annual Report Full Text." It contains detailed financial data, business overview, management discussion and analysis, financial statements, and other comprehensive information typical of an interim or quarterly report. The document covers the first half of 2018, includes extensive financial metrics, operational analysis, risk factors, and other substantive financial and business information. It is not a brief announcement or a certification letter but a full report. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2018
2018-08-07 Chinese
2018年半年度业绩快报
Earnings Release Classification · 95% confidence The document is titled as a '2018 Semi-Annual Performance Express Report' (半年度业绩快报), which indicates it is a preliminary financial performance announcement for the half-year period. It contains key financial data and performance metrics for the first half of 2018, including revenue, profit, and earnings per share, but it explicitly states that the data is preliminary and unaudited. The document length is short (1245 characters), and it is a brief announcement of financial results rather than a comprehensive interim report with full financial statements and detailed analysis. According to the classification rules, such preliminary financial data announcements correspond to an Earnings Release (ER) rather than a full Interim/Quarterly Report (IR). H1 2018
2018-07-09 Chinese
关于控股子公司获得政府补助的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving government subsidies for its subsidiaries. It includes details about the subsidy amounts, dates, and expected impact on profits. The document is only 1152 characters long and does not contain any financial statements or detailed financial analysis. It is an announcement of a specific event (government subsidy receipt) rather than a full financial report or regulatory filing. Therefore, it fits best into the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories.
2018-06-20 Chinese
关于控股股东增持公司股份的进展公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement regarding the progress of a controlling shareholder increasing their shareholding in the company. It details the number of shares purchased, the percentage of total shares, the purpose of the increase, and compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The document is short (1195 characters) and focuses on shareholding changes by a major shareholder. This fits the definition of a Major Shareholding Notification (MRQ).
2018-06-04 Chinese
关于投资设立杭州优胜美特药物研究院有限公司的公告
Regulatory Filings Classification · 95% confidence The document is an announcement by 普洛药业股份有限公司 regarding an investment to establish a new research institute, 杭州优胜美特药物研究院有限公司. It details the investment purpose, the company's strategy, and the basic information about the new entity. There is no financial report, no audit information, no voting results, no management changes, no earnings data, or other report types. The document is a regulatory announcement about a capital investment activity but does not describe a financing update or capital structure change in detail. It fits best as a general regulatory announcement about a corporate action that does not fall into other specific categories. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length is short and it is not a report publication announcement or certification. Confidence is high due to clear content and format.
2018-05-22 Chinese
关于控股股东增持本公司股份的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from 普洛药业股份有限公司 regarding the increase in shareholding by its controlling shareholder 横店集团控股有限公司. It details the number of shares increased, the percentage of total share capital, the method of purchase, and compliance with relevant securities laws. There is no financial report, earnings data, or management discussion. The content focuses on shareholding changes by a major shareholder, which fits the definition of a Major Shareholding Notification (MRQ). The document length is short and it is an announcement, not a report or filing of financial results.
2018-05-18 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.